GENE:LSE:LSE-UBS (Irl) ETF Public Limited Company - Global Gender Equality UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 1521.7

Change

+8.50 (+0.56)%

Market Cap

USD 0.27B

Volume

125.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-2.75 (-1.59%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-4.64 (-3.61%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.02 (+0.10%)

USD 535.31B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.04 (+0.29%)

USD 535.31B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.40 (+0.56%)

USD 266.08B
0QZO:LSE 0QZO

-1.20 (-1.32%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.06 (+0.18%)

USD 205.22B
0QZ3:LSE Qualcomm Inc.

-0.53 (-0.31%)

USD 202.26B
0R24:LSE Intel Corp.

-0.78 (-3.83%)

USD 196.14B

ETFs Containing GENE:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.16% 48% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.16% 47% F 51% F
Trailing 12 Months  
Capital Gain 13.30% 61% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.30% 60% D- 62% D
Trailing 5 Years  
Capital Gain 48.31% 67% D+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.31% 65% D 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 17.56% 86% B+ 84% B
Dividend Return 17.56% 86% B+ 84% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 192.51% 11% F 9% A-
Risk Adjusted Return 9.12% 35% F 47% F
Market Capitalization 0.27B 58% F 44% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.